- Home
- Publications
- Publication Search
- Publication Details
Title
HDL proteome remodeling associates with COVID-19 severity
Authors
Keywords
HDL, COVID-19, Quantitative proteomics, Infection
Journal
Journal of Clinical Lipidology
Volume 15, Issue 6, Pages 796-804
Publisher
Elsevier BV
Online
2021-10-31
DOI
10.1016/j.jacl.2021.10.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune determinants of COVID-19 disease presentation and severity
- (2021) Petter Brodin NATURE MEDICINE
- Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19
- (2021) Annabelle Dupont et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Low HDL and high triglycerides predict COVID-19 severity
- (2021) Lluís Masana et al. Scientific Reports
- HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure
- (2020) Markus Trieb et al. JOURNAL OF HEPATOLOGY
- Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study
- (2020) Dan Wang et al. BMC INFECTIOUS DISEASES
- Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism
- (2020) Yan Liu et al. CURRENT OPINION IN LIPIDOLOGY
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis
- (2020) Huan Li et al. JOURNAL OF INFECTION
- HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro
- (2020) YiWen Fan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis
- (2020) Mark Trinder et al. CIRCULATION
- Comparing Data-Independent Acquisition and Parallel Reaction Monitoring in Their Abilities To Differentiate High-Density Lipoprotein Subclasses
- (2019) Amanda R. M. Silva et al. JOURNAL OF PROTEOME RESEARCH
- U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies
- (2017) Christian M Madsen et al. EUROPEAN HEART JOURNAL
- Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1
- (2017) John T. Melchior et al. JOURNAL OF LIPID RESEARCH
- High-Density Lipoprotein–Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1Highlights
- (2016) Mario Ruiz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Surfactant protein B: From biochemistry to its potential role as diagnostic and prognostic marker in heart failure
- (2016) Cristina Banfi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
- (2015) Tomáš Vaisar et al. JOURNAL OF LIPID RESEARCH
- Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics
- (2015) Graziella E. Ronsein et al. Journal of Proteomics
- Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone
- (2015) Graziella E. Ronsein et al. MOLECULAR & CELLULAR PROTEOMICS
- HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1to limit vascular inflammation
- (2015) Sylvain Galvani et al. Science Signaling
- HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1to limit vascular inflammation
- (2015) Sylvain Galvani et al. Science Signaling
- Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach
- (2014) Steven A. Carr et al. MOLECULAR & CELLULAR PROTEOMICS
- Understanding high-density lipoprotein function in disease: Recent advances in proteomics unravel the complexity of its composition and biology
- (2014) Ruth Birner-Gruenberger et al. PROGRESS IN LIPID RESEARCH
- The Effects of Type 2 Diabetes on Lipoprotein Composition and Arterial Stiffness in Male Youth
- (2013) Scott M. Gordon et al. DIABETES
- Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
- (2013) Amy S. Shah et al. JOURNAL OF LIPID RESEARCH
- Multi-dimensional Co-separation Analysis Reveals Protein–Protein Interactions Defining Plasma Lipoprotein Subspecies
- (2013) Scott M. Gordon et al. MOLECULAR & CELLULAR PROTEOMICS
- Proteomic profiling following immunoaffinity capture of high-density lipoprotein: Association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis
- (2012) Junji Watanabe et al. ARTHRITIS AND RHEUMATISM
- High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A
- (2012) Markus Tölle et al. CARDIOVASCULAR RESEARCH
- Psoriasis alters HDL composition and cholesterol efflux capacity
- (2012) Michael Holzer et al. JOURNAL OF LIPID RESEARCH
- Serum Amyloid A in Uremic HDL Promotes Inflammation
- (2012) T. Weichhart et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started